America’s Bioventus Buys Out Israel’s CartiHeal for $500 Million
(CartiHeal Demonstrates Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects) Bioventus, an American orthologics company, has exercised an option that it held to acquire Israeli medical device company CartiHeal. The price is $500 million with $360 million being paid out in front in cash. Pursuant to its Option and […]
Continue Reading